NCAM1 and myeloid sarcoma: The total T cells and the CD56− T cell fraction in the ICU, MS, and CCP groups had a higher proportion of HLA-DR+ cells compared to healthy controls, while in the CD56+ T cell fraction, COVID-19-mediated activation was registered only in convalescents (Figure 4a).